Pharmacokinetic drug-drug interactions between calcineurin inhibitors and proliferation signal inhibitors with anti-microbial agents: Implications for therapeutic drug monitoring

Journal of Heart and Lung Transplantation

Volumn 30, Issue 2, 2011, Pages 124-135

  Page II, Robert L ^a   Mueller, Scott W ^a   Levi, Marilyn E ^b   Lindenfeld, Joann ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

antimicrobial agents; calcineurin inhibitors; drug drug interactions; pharmacokinetics; proliferation signal agents

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; CALCINEURIN INHIBITOR; CASPOFUNGIN; CEFTRIAXONE; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLARITHROMYCIN; CLOTRIMAZOLE; CYCLOSPORIN; ERYTHROMYCIN; EVEROLIMUS; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; LEVOFLOXACIN; METRONIDAZOLE; MICAFUNGIN; NAFCILLIN; POSACONAZOLE; RAPAMYCIN; RIFABUTIN; RIFAMPICIN; SULFADIAZINE; TACROLIMUS; TICARCILLIN; UNINDEXED DRUG; VORICONAZOLE;

AREA UNDER THE CURVE; ARTICLE; ASPERGILLOSIS; CANDIDIASIS; DRUG ANTAGONISM; DRUG CLEARANCE; DRUG METABOLISM; DRUG MONITORING; DRUG POTENTIATION; GINGIVA HYPERPLASIA; GLUCOSE INTOLERANCE; HUMAN; LIVER TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; CALCINEURIN; CYCLOSPORINE; DRUG INTERACTIONS; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SIGNAL TRANSDUCTION; TACROLIMUS;

EID: 78650950571     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.09.001     Document Type: Article

References (83)

1. J. Lindenfeld, R.L. Page II, and R. Zolty Drug therapy in the heart transplant recipient: Part III: Common medical problems Circulation 111 2005 113 117
2. J.D. Briggs Causes of death after renal transplantation Nephrol Dial Transplant 16 2001 1545 1549
3. R.L. Page II, G.G. Miller, and J. Lindenfeld Drug therapy in the heart transplant recipient: Part IV: Drugdrug interactions Circulation 111 2005 230 239 (Pubitemid 40139736)
4. T.R. Srinivas, H.U. Meier-Kriesche, and B. Kaplan Pharmacokinetic principles of immunosuppressive drugs Am J Transplant 5 2005 207 217
5. U. Christians, T. Strom, and Y.L. Zhang Active drug transport of immunosuppressants: new insights for pharmacokinetics and pharmacodynamics Ther Drug Monit 28 2006 39 44
6. D.J. Back, and J.F. Tjia Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes Br J Clin Pharmacol 32 1991 624 626
7. E. Vasquez, R. Pollak, and E. Benedetti Clotrimazole increases tacrolimus blood levels: a drug interaction in kidney transplant patients Clin Transplant 15 2001 95 99
8. J.E. Martin, A.J. Daoud, and T.J. Schroeder The clinical and economic potential of cyclosporin drug interactions Pharmacoeconomics 15 1999 317 337
9. A.J. Romero, P.L. Pogamp, and L.G. Nilsson Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients Clin Pharmacol Ther 71 2002 226 234
10. D.R. Kuypers, K. Claes, and P. Evenepoel Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient Transplantation 81 2006 1750 1752
11. Vfend [package insert] March 2008 Pfizer New York
12. M.P. Pai, and S. Allen Voriconazole inhibition of tacrolimus metabolism Clin Infect Dis 36 2003 1089 1091
13. J.A. Barbara, A.R. Clarkson, and J. LaBrooy Candida albicans arthritis in a renal allograft recipient with an interaction between cyclosporin and fluconazole Nephrol Dial Transplant 8 1993 263 266
14. K. Sud, B. Singh, and V.S. Krishna Unpredictable cyclosporinefluconazole interaction in renal transplant recipients Nephrol Dial Transplant 14 1999 1698 1703
15. D.M. Canafax, N.M. Graves, and D.M. Hilligoss Increased cyclosporine levels as a result of simultaneous fluconazole and cyclosporine therapy in renal transplant recipients: a double-blind, randomized pharmacokinetic and safety study Transplant Proc 23 1991 1041 1042
16. R. Manez, M. Martin, and D. Raman Fluconazole therapy in transplant recipients receiving FK506 Transplantation 57 1994 1521 1523
17. Y. Hairhara, M. Makuuchi, and H. Kawarasaki Effect of fluconazole on blood levels of tacrolimus Transplant Proc 31 1999 2767
18. Noxafil [package insert] October 2006 Schering Corp Kenilworth, NJ
19. A. Sansone-Parsons, G. Krishna, and M. Martinho Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus Pharmacotherapy 27 2007 825 834
20. A.J. Ullmann Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole Curr Med Res Opin 19 2003 263 271
21. C. Sanz-Rodriguez, M. Lopez-Duarte, and M. Jurado Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections Bone Marrow Transplant 34 2004 13 20
22. Cancidas [package insert] February 2010 Merck North Wales, PA
23. Mycaimine [package insert] April 2005 Astellas Pharma Deerfield, IL
24. M.F. Hebert, D.K. Blough, and R.W. Townsend Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers J Clin Pharmacol 45 2005 1018 1024
25. M.F. Hebert, R.W. Townsend, and S. Austin Concomitant cyclosporine and micafungin pharmacokinetics in healthy volunteers J Clin Pharmacol 45 2005 954 960
26. Eraxis [package insert] February 2006 Pfizer New York
27. J.A. Dowell, M. Stogniew, and D. Krause Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine J Clin Pharmacol 45 2005 227 233
28. J. Soto Alvarez, J.A. Sacristan Del Castillo, and M.J. Alsar Ortiz Interaction between ciclosporin and ceftriaxone Nephron 59 1991 681 682
29. C.C. Lang, S.K. Jamal, and Z. Mohamed Evidence of an interaction between nifedipine and nafcillin in humans Br J Clin Pharmacol 55 2003 588 590
30. J. Huwyler, M.B. Wright, and H. Gutmann Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazolyl-penicillin antibiotic flucloxacillin Curr Drug Metab 7 2006 119 126
31. S.A. Veremis, M.S. Maddux, and R. Pollak Subtherapeutic cyclosporine concentrations during nafcillin therapy Transplantation 43 1987 913 915
32. J. Zazgornik, W. Schein, and K. Heimberger Potentiation of neurotoxic side effects by coadministration of imipenem to cyclosporine therapy in a kidney transplant recipientsynergism of side effects or drug interaction? Clin Nephrol 26 1986 265 266
33. W. Mraz, B. Sido, and M. Knedel Concomitant immunosuppressive and antibiotic therapyreduction of cyclosporine A blood levels due to treatment with imipenem/cilastatin Transplant Proc 19 1987 4017 4020
34. R.A. McLellan, R.K. Drobitch, and M. Monshouwer Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human Drug Metab Dispos 24 1996 1134 1138
35. M. Nasir, C. Rotellar, and M. Hand Interaction between ciclosporin and ciprofloxacin Nephron 57 1991 245 246
36. J. Borras-Blasco, V. Conesa-Garcia, and A. Navarro-Ruiz Ciprofloxacin, but not levofloxacin, affects cyclosporine blood levels in a patient with pure red blood cell aplasia Am J Med Sci 330 2005 144 146
37. D.H. Van Buren, J. Koestner, and A. Adedoyin Effect of ciprofloxacin on cyclosporine pharmacokinetics Transplantation 50 1990 888 889
38. S. Federico, R. Carrano, and D. Capone Pharmacokinetic interaction between levofloxacin and ciclosporin or tacrolimus in kidney transplant recipients: ciclosporin, tacrolimus and levofloxacin in renal transplantation Clin Pharmacokinet 45 2006 169 175
39. A.M. Fietta, and F. Meloni Lung transplantation: the role of azithromycin in the management of patients with bronchiolitis obliterans syndrome Curr Med Chem 15 2008 716 723
40. I.D. Padhi, P. Long, and M. Basha Interaction between tacrolimus and erythromycin Ther Drug Monit 19 1997 120 122
41. P. Periti, T. Mazzei, and E. Mini Pharmacokinetic drug interactions of macrolides Clin Pharmacokinet 23 1992 106 131
42. R.B. Ibrahim, E.M. Abella, and P.H. Chandrasekar Tacrolimusclarithromycin interaction in a patient receiving bone marrow transplantation Ann Pharmacother 36 2002 1971 1972
43. P.K. Kunicki, and M. Sobieszczanska-Malek Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient Ther Drug Monit 27 2005 107 108
44. I.S. Sketris, M.R. Wright, and M.L. West Possible role of the intestinal P-450 enzyme system in a cyclosporineclarithromycin interaction Pharmacotherapy 16 1996 301 305
45. T. Mori, Y. Aisa, and T. Nakazato Tacrolimusazithromycin interaction in a recipient of allogeneic bone marrow transplantation Transplant Int 18 2005 757 758 (Pubitemid 41726846)
46. R.L. Page II, J.M. Ruscin, and D. Fish Possible interaction between intravenous azithromycin and oral cyclosporine Pharmacotherapy 21 2001 1436 1443
47. M. West, J. Pirenne, and B. Chavers Clostridium difficile colitis after kidney and kidneypancreas transplantation Clin Transplant 13 1999 318 323
48. M. Maurice, L. Pichard, and M. Daujat Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture FASEB J 6 1992 752 758
49. G. Cantelli-Forti, M. Paolini, and P. Hrelia Effects of metronidazole, azanidazole, and azathioprine on cytochrome P450 and various mono-oxygenase activities in hepatic microsomes from control and induced mice Arch Toxicol Suppl 11 1987 264 269
50. R.L. Page II, P.M. Klem, and C. Rogers Potential elevation of tacrolimus trough concentrations with concomitant metronidazole therapy Ann Pharmacother 39 2005 1109 1113
51. C.K. Finch, C.R. Chrisman, and A.M. Baciewicz Rifampin and rifabutin drug interactions: an update Arch Intern Med 162 2002 985 992
52. V.L. Freitag, R.D. Skifton, and K.D. Lake Effect of short-term rifampin on stable cyclosporine concentrations Ann Pharmacother 33 1999 871 872
53. C. Vandevelde, A. Chang, and D. Andrews Rifampin and ansamycin interactions with cyclosporine after renal transplantation Pharmacotherapy 11 1991 88 89
54. A. Lopez-Montes, E. Gallego, and E. Lopez Treatment of tuberculosis with rifabutin in a renal transplant recipient Am J Kidney Dis 44 2004 e59 e63
55. J. Wallwork, C.G. McGregor, and F.C. Wells Cyclosporin and intravenous sulphadimidine and trimethoprim therapy Lancet 1 1983 366 367
56. C.H. Spes, C.E. Angermann, and H.U. Stempfle Sulfadiazine therapy for toxoplasmosis in heart transplant recipients decreases cyclosporine concentration Clin Invest 70 1992 752 754
57. X. Wen, J.S. Wang, and J.T. Backman Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively Drug Metab Dispos 30 2002 631 635
58. D.S. Tatro Drug interaction facts Facts and comparisons 2009 Wolters Kluwer Health Chicago, IL
59. M.K. Stamatakis, and J.G. Richards Interaction between quinupristin/dalfopristin and cyclosporine Ann Pharmacother 31 1997 576 578
60. A.S. Mathis, N. Shah, and G.T. Knipp Interaction of chloramphenicol and the calcineurin inhibitors in renal transplant recipients Transplant Infect Dis 4 2002 169 174
61. D.J. Taber, R.E. Dupuis, and K.D. Hollar Drugdrug interaction between chloramphenicol and tacrolimus in a liver transplant recipient Transplant Proc 32 2000 660 662
62. S. Yamaguchi, Y.L. Zhao, and M. Nadai Involvement of the drug transporters p glycoprotein and multidrug resistance-associated protein Mrp2 in telithromycin transport Antimicrob Agents Chemother 50 2006 80 87
63. A.N. Stumpf, C. Schmidt, and W. Hiddemann High serum concentrations of cyclosporin related to administration of tigecycline Eur J Clin Pharmacol 65 2009 101 103
64. N.R. Srinivas Tigecycline and cyclosporine interactionan interesting case of biliary-excreted drug enhancing the oral bioavailability of cyclosporine Eur J Clin Pharmacol 65 2009 543 544
65. K. Yasuda, A. Ranade, and R. Venkataramanan A comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine Drug Metab Dispos 36 2008 1689 1697
66. R. Thurnheer, I. Laube, and R. Speich Possible interaction between clindamycin and cyclosporin BMJ 319 1999 163
67. J. Lindenfeld, G.G. Miller, and S.F. Shakar Drug therapy in the heart transplant recipient: Part II: Immunosuppressive drugs Circulation 110 2004 3858 3865 (Pubitemid 40023985)
68. G.I. Snell, V.G. Valentine, and P. Vitulo Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial Am J Transplant 6 2006 169 177
69. Afinitor [package insert] February 2009 Novartis Pharmaceuticals East Hanover, NJ
70. L.C. Floren, U. Christians, and J.J. Zimmerman Sirolimus oral bioavailability increases ten-fold with concomitant ketoconazole [abstract] Clin Pharmacol Ther 65 1999 159
71. P.P. Thomas, J. Manivannan, and G.T. John Sirolimus and ketoconazole co-prescription in renal transplant recipients Transplantation 77 2004 474 475
72. J.M. Kovarik, D. Beyer, and M.N. Bizot Blood concentrations of everolimus are markedly increased by ketoconazole J Clin Pharmacol 45 2005 514 518
73. D.R. Kuypers, K. Claes, and P. Evenepoel Drug interaction between itraconazole and sirolimus in a primary renal allograft recipient Transplantation 79 2005 737
74. F.M. Marty, C.M. Lowry, and C.S. Cutler Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation Biol Blood Marrow Transplant 12 2006 552 559
75. A.S. Mathis, N.K. Shah, and G.S. Friedman Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases Transplant Proc 36 2004 2708 2709
76. E.M. Billaud, C. Antoine, and M. Berge Management of metabolic cytochrome P450 3A4 drugdrug interaction between everolimus and azole antifungals in a renal transplant patient Clin Drug Invest 29 2009 481 486
77. M.J. Cervelli Fluconazolesirolimus drug interaction Transplantation 74 2002 1477 1478
78. Rapamune [package insert] April 2010 Wyeth-Ayerst Philadelphia
79. K. Claesson, C. Brattstrom, and J.T. Burke Sirolimus and erythromycin interaction: two cases Transplant Proc 33 2001 2136
80. D. Capone, G. Palmiero, and A. Gentile A pharmacokinetic interaction between clarithromycin and sirolimus in kidney transplant recipient Curr Drug Metab 8 2007 379 381
81. J.M. Kovarik, C.H. Hsu, and L. McMahon Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications Clin Pharmacol Ther 70 2001 247 254
82. J.M. Kovarik, D. Beyer, and M.N. Bizot Effect of multiple-dose erythromycin on everolimus pharmacokinetics Eur J Clin Pharmacol 61 2005 35 38
83. J.M. Kovarik, S. Hartmann, and J. Figueiredo Effect of rifampin on apparent clearance of everolimus Ann Pharmacother 36 2002 981 985